Science Daily is fantastic research based website. The site is massive though with many, many daily updates. Keeping up with important mental health research on this site can be a daunting challenge for practitioners and the general public. Hence, I plan to provide weekly to semi-weekly updates on The Behavioral Medicine Report in a similar […]
Today’s update from the National Institute of Health/National Institute of Mental Health includes newly announced research on autism, ADHD, and child abuse. The ADHD story discusses an important update to the now classic Multimodal Treatment Study of Children with ADHD (MTA) study so be sure to view that article. (more…)
The National Institutes of Health (NIH) News service recently announced in a press release* that approximately $60 million will be committed to future Autism research. Funds are being received through The American Recovery and Reinvestment Act (ARRA). The grants will be issued under the name, “Research to Address the Heterogeneity in Autism Spectrum Disorders,” to […]
Many neurofeedback clinicians and researchers are already aware of this latest free resource to be added to The Behavioral Medicine Report. However, I want to alert the general public, students, and other interested persons to this excellent document from The International Society of Neurofeedback and Research (ISNR): The Comprehensive Neurofeedback Bibliography. Check the end of […]
Roulette William Smith, Ph.D. details a potentially ground breaking theory that purports to unravel the mystery surrounding the underlying causative factors of autism spectrum disorders, schizophrenia, and a host of other mental and physical illnesses in his paper entitled, “Inferring an Autovirulent Epigenetic Etiology for the Autism Spectrum and Schizophrenia*.” Dr. Smith’s theory originated from […]
Autism Speaks and the Autism Clinical Trials Network report that a new low dose, melt-in-your-mouth version of Fluoxetine failed to reduce repetitive behaviors in children and adolescents diagnosed with Autism. Physicians’ clinical observations that Fluoxetine controlled these behaviors spurred this research. Fluoxetine is selective serotonin reuptake inhibitor (SSRI) that is commonly referred to as a […]
I am very pleased to provide the response of our first invited guest commentator, Mirjam Kouijzer, lead author of the research discussed in the recent BMED Report article, Neurofeedback For Autistic Spectrum Disorders: Promising Results In A Small Sample. The BMED Report extends a warm thanks to Mirjam Kouijzer and Hein van Schie for this […]
This current report extends the initial findings of “Neurofeedback For Autistic Spectrum Disorders: Promising Results In A Small Sample” to a 1 year follow-up of the same participants with Autism Spectrum Disorders (ASD). Recall from the initial study that participants with ASD experienced statistically meaningful improvements in a variety of executive functioning, social, and behavioral […]
Recent Comments